Elequin Capital’s Ionis Pharmaceuticals IONS Stock Holding History

Elequin Capital’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$15.6K	Sell	208 -503	-71%	-$39.7K	﹤0.01%	283
2025 Q4	$56.2K	Buy	+711	New	+$53.5K	﹤0.01%	136
2025 Q1	–	Sell	-325	Closed	-$11.4K	–	475
2024 Q4	$11.4K	Sell	325 -112	-26%	-$4.19K	﹤0.01%	307
2024 Q3	$17.5K	Buy	+437	New	+$20.3K	﹤0.01%	191
2024 Q2	–	Sell	-474	Closed	-$20.5K	–	267
2024 Q1	$20.5K	Buy	+474	New	+$22.6K	﹤0.01%	50
2022 Q3	–	Sell	-532	Closed	-$20K	–	614
2022 Q2	$20K	Buy	532 +172	+48%	+$6.49K	﹤0.01%	193
2022 Q1	$13K	Buy	+360	New	+$11.8K	﹤0.01%	151

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Elequin Capital's IONS Position: Q1 2026 in Review

Elequin Capital reduced its Ionis Pharmaceuticals (IONS) stake by 71% in Q1 2026, selling an estimated $39.7K and leaving 208 shares worth $15.6K. The position accounts for ﹤0.01% of the portfolio, ranked #283.

Elequin Capital first reported a position in IONS in Q1 2022 and has held it in 7 quarters since. The position peaked at $56.2K in Q4 2025. 493 funds tracked by Wall St. Rank hold IONS as of Q1 2026.

Elequin Capital held 208 shares of Ionis Pharmaceuticals worth $15.6K as of Q1 2026.
Elequin Capital sold 503 Ionis Pharmaceuticals shares in Q1 2026, an estimated $39.7K.
Ionis Pharmaceuticals made up ﹤0.01% of Elequin Capital's portfolio in Q1 2026, its #283 holding.
Elequin Capital first reported a position in Ionis Pharmaceuticals in Q1 2022 and has held it in 7 quarters since.
Elequin Capital's Ionis Pharmaceuticals position peaked at $56.2K in Q4 2025.
493 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2026.

Based on Elequin Capital's 13F filing for Q1 2026, filed 11 May 2026.